Clonal Dominance Defines Metastatic Dissemination in Pancreatic Cancer
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Unperturbed Clonal Dynamics Reveal Alternating Clonal Dominance
as a Distinct Features of Tumor Growth

Introduction
Tumors can be viewed as a complex ecosystem where multiple sub-clones harboring specific functional
phenotype compete and co-evolve. The evolution and dynamics of individual clonal behavior in tumor has long
been a topic of high interest, as it is essential to our understanding of how tumors progress, evolve and adapt to
therapeutics. However, currently there are no robust models that allow the systematic monitoring of clonal
dynamics overtime, as well as for paired functional characterization of individual sub-clones with specific
behaviors of interest. Therefore, we established a high resolution longitudinal clonal tracing model that
comprehensively capture lineage dynamics during tumor expansion and dissemination without perturbing the
natural expansion of the tumor.

Functional Characterization of Sub-clones via Clonal Isolation

“K-plot” displaying longitudinal clonal dynamics in the primary
tumor over 14 weeks. Each barcode is converted into %
representation and normalized to the “injected” time point for
each time point and connected. Each line represents a unique
barcode’s longitudinal dynamic in terms of individual clonal
fitness in the tumor. Graph indicates multiple clonal evolution
patterns (displaying 12 patterns) over time.

Generation of Orthotopic Clonal Replica Tumors
Longitudinal clonal dynamics in
the primary tumor over 14 weeks
by
quartiles
based
on
accumulative tumor mass at the
last time point (week 14). Top to
bottom panel display clusters of
clonal lineages with similar
behavior dynamics at quartile of
0% – 25%, 25% –50%, 50% –
75%, and 75% –100% of the
week 14 tumor respectively.
Each line represents a unique
barcode’s longitudinal dynamic in
terms of % representation. Each
cluster’s X-axis indicates time of
collection and Y-axis indicates %
tumor representation of the
barcode. The number outside the
bracket indicates the cluster
name, and the number within the
bracket indicates the exact
number of barcodes within the
cluster
(darker
colors
are
associated with larger number of
barcodes within the cluster).
Patient derived xenograft cell lines from pancreatic cancer (primary tumor) are barcoded with a high complexity
barcode library (~50M variations) at low MOI for 1 unique barcode per cell. Barcoded cells are then stabilized in
vitro where clones with long-term self-renewal properties are naturally enriched. Post stabilization, cells are
expanded and transplanted orthotopically in mouse cohorts. Primary tumor (pancreas) and distal organs are
collected at various time points and sequenced for barcode information.

High-throughput clonal isolation workflow allows us to isolate and culture clones of interest (pro-met vs non-met)
(left); Mutational landscape and CNV analysis of pro-met (M-1–3) and non-met (NM-1–3) clones from WES data
(mid and right)

Pro-Metastatic Clones Upregulation in NMDA Pathway

Quantitative Assessment of Clonal Dissemination Dynamics Uncovers
Clonal Dominance as a Major Determinant of Metastasis
Heat map of differential gene expression of isogenic clones with distinct metastatic potential as determined in
longitudinal oCRT studies (left). IPA analysis of pro-met (M-1–3) and non-met (NM-1–3) clones identifies
enrichment of glutamate receptors and neurovascular coupling signaling pathways in pro-met lineages (mid).
Basal intracellular calcium concentration of clonal lineages selected on the basis of differential metastatic
behavior (top right). Validation of clonal DE in NMDA receptor, AMPA receptor, CaMK by qPCR (bottom right).

Orthotopic Clonal Replica (oCRT) Tumors - Biological Reproducibility

Orthotopic Injection

NMDAR Antagonist Reduce Fitness and Invasion of Pro-Metastatic Clones
Invasion assay

(Left) Cumulative cell number at distant sites (liver, lung, blood and ascites) over time. Cell number at each
time point is converted based on spike-in scales. (Right) Barcode complexity at distant sites over time.

Invasion assay + Memantine

Two mouse were sacrificed at each time point and their respective tumor clonal lineage composition and relative
abundance is quantitatively analyzed from barcode readout via NGS. The number of paired barcodes shared
between two biological replicates at the same time point and their relative tumor mass representation is shown in
the upper Venn diagram. Each lineage’s relative abundance (%, log scale) between two biological replicates are
plotted as gray dots in X-Y scatter plots. The number of common barcodes shared across all time points and their
relative tumor mass representation is shown in the lower Venn diagram. Each lineage’s relative abundance (%, log
scale) between two biological replicates are plotted as red dots in X-Y scatter plots.

Dynamic subclonal growth in liver (left) and lung (right). Cell number at each time point is converted based
on spike-in scales. Lineage behavior was grouped into discrete dynamic growth patterns (clusters) over
time. The number outside the bracket indicates the cluster name, and the number within the bracket
indciates the exact number of barcodes within the cluster (darker colors are associated with larger number
of barcodes within the cluster).

Statistical reproducibility Based on Parametric Bootstrap

Memantine in vivo

Representative images of invasion assay indicating the basal invasion potential of two pro-met and two non-met
subclones (top left) and the effect of the non-competitive NMDA antagonist 25 or 100 µM memantine on invasive
potential of cells (bottom left). MTT assay to evaluate effects of a range of memantine concentrations on viability
of clones of interest (top right). Effect of memantine on liver metastasis of 2 metastatic isolated clones (bottom
right).

Metastasis Gene Signature May Inform Clinical Outcome

Use statistically robustness test on the clonal (barcode) lineage
composition amongst CRTs cohorts to inform us whether clonal replica
tumors composition and intra-tumor lineages expansion were relatively
similar across cohorts.
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Statistic 1:
T1 is the Pearson correlation coefficient between populations Px and
Py. If T1 is close to 1, then A and B is similar.
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Statistic 2:
T2 is the Euclidean distance between Px and Py,
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If T2 is close to 0, then A and B is similar.
Simulation: Bootstrap resampling approach to perform similarity test
(5000X)
Baseline criteria for similarity: Based on differences between
empirical data from the two injected vials (identical technical
replicates) and two week 4 samples.
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(Left) The 100 most enriched and 100 most downregulated genes from transcriptomic analysis in DE analysis in
the three pro-met subclones versus the three non-met subclones were used to derive a pro-met signature.
scRNAseq analysis of parental patient-derived xenograft cell line (n = 3,397) was used to identify clones with
metastatic potential. (Right) Kaplan-Meier survival analysis of patients in the TCGA pancreatic cancer cohort
separated by expression or not of the pro-met transcriptomic signature.

Natural divergence of clones over time (stochastic aspect of
tumor expansion)

Conclusions
(Left) Heatmap of average subclonal abundance (percentage) in the primary tumors with
dissemination/metastasis status (yes/no) at week 14. Dissemination of each subclone is indicated on the
left of each heat map in quartiles (yellow, no dissemination; blue, dissemination). (Right) Average clonal
abundance in the primary tumors (percentage) at week 14 for metastatic clones (top) and non-metastatic
clones (bottom).

• Expanding primary tumors are extremely dynamic and undergo a continuous reshuffling of their clonal architecture,
even in the absence of any external perturbations, a behavior we named alternating clonal dominance Page 1
• Clonal dominance and cell intrinsic long-term replicative potential in the primary tumor are key factors that dictate
clonal dissemination to secondary organs.
• Functional upregulation of glutamatergic neural/synaptic signaling in metastatic clones drives invasion and
dissemination and represents an actionable therapeutic target to suppress tumor metastasis.
• A transcriptomic signature to detect primary tumor cells with the ability to sustain distant metastases may predict
patient survival.

